References
- Lui K, Lee SK, Kusuda S, Adams M, Vento M, Reichman B, Darlow BA,
Lehtonen L, Modi N, Norman M, et al. Trends in outcomes for
neonates born very preterm and very low birth weight in 11 high-income
countries. J Pediatr, 215 (2019), pp. 32-40.e14
- Wu KY, Jensen EA, White AM, Wang Y, Biko DM, Nilan K, Fraga MV,
Mercer-Rosa L, Zhang H, Kirpalani H.
Characterization
of disease phenotype in very preterm infants with severe
bronchopulmonary dysplasia. Am J Respir Crit Care Med.
2020;201(11):1398-1406.
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit
Care Med 2001;163(7):1723-1729.
- Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon
L, Jobe A. Summary Proceedings from the bronchopulmonary dysplasia
group. Pediatrics 2006;117(3 Pt 2):S52-S56.
- Shepherd EG, Clouse BJ, Hasenstab KA, Sitaram S, Malleske DT, Nelin
LD, Jabcherla SR. Infant pulmonary function testing and phenotypes in
severe bronchopulmonary dysplasia. Pediatrics 2018;141(5):e20173350
[epub ahead of print]
- Smyth JA, Tabachnik E, Duncan WJ, Reilly BJ, Levison H. Pulmonary
function and bronchial hyperreactivity in long-term survivors of
bronchopulmonary dysplasia. Pediatrics 1981;68(3):336-340.
- Clark RH, Bloom BT, Spitzer AB, Gerstmann DR. Reported medication use
in the neonatal intensive care unit: data from a large national data
set. Pediatric 2006; 117(6):1979-1987.
- Allen J, Zwerdling R, Ehrenkranz R, Gaultier C, Geggel R, Greenough A,
Kleinman R, Klijanowicz A, Martinez F, Ozdemir A, Et al. Statement on
the care of the child with chronic lung disease of infancy and
childhood. Am J Respir Crit Care Med 2003; 168(3):356-396.
- Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Inhaled
bronchodilator use for infants with bronchopulmonary dysplasia. J
Perinatology 2015;35:61-66.
- Guaman MC, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point
prevalence, clinical characteristics, and treatment variation for
infants with severe bronchopulmonary dysplasia. Am J Perinatol
2015;32(10):960-967.
- Bamat NA, Kirpalani H, Feudtner C, Jensen EA, Laughon MM, Zhang H,
Monk HM, Passarella M, Lorch SA. Medication use in infants with severe
bronchopulmonary dysplasia admitted to United States children’s
Hospitals. J Perinatol 2019;39(9):1291-1299.
- Ng Gy, da Silca O, Ohlsson A. Bronchodilators for the prevention and
treatment of chronic lung disease in preterm infants. Cochrane
Database Syst Rev. 2012; 6.
- Fayon M, Tayara N, Germain C, Choukroum ML, De La Roque ED, Chêne G,
Breilh D, Marthan R, Demarquez JL. Efficacy and tolerance of high-dose
inhaled ipratropium bromide vs terbutaline in intubated premature
human neonates. Neonatology 2007;91:167-173.
- Lee H, Arnon S, Silverman M. Bronchodilator aerosol administered by
metered dose inhaler and spacer in subacute neonatal respiratory
distress syndrome. Arch Dis in Childhood 1994;70:218-22.
- Pfenninge J, Aebi C. Respiratory response to salbutamol (albuterol) in
ventilator-dependent infants with chronic lung disease: pressurised
aerosol delivery versus intravenous injection. Intensive Care Medicine
1993;19:251-5.
- Rotschild A, Solimano A, Puterman M, Smyth J, Sharma A, Albersheim S.
Increased compliance in response to salbutamol in premature infants
with developing bronchopulmonary dysplasia. J Pediatrics
1989;115:984-91.
- Sivakumar D, Bosque E, Goldman SL. Bronchodilator delivered by metered
dose inhaler and spacer improves respiratory system compliance more
than nebulizer-delivered bronchodilator in ventilated premature
infants. Pediatr Pulm 1999;27:208-12.
- Wilkie RA, Bryan MH. Effect of bronchodilators on airway resistance in
ventilator-dependent neonates with chronic lung disease. J Pediatrics
1987;111:278-83.
- Morrow Dk, Schilling D, McEvoy CT. Response to bronchodilators in very
preterm infants with evolving bronchopulmonary dysplasia. Res Rep
Neonatol 2015; 5:113-117.
- Levin DL, Garg A, Hall LJ, Slogic S, Jarvis JD, Leiter JC. A
prospective randomized controlled blinded study of three
bronchodilators in infants with respiratory syncytial virus
bronchiolitis on mechanical ventilation. Pediatr Crit Care Med
2008;9:598-604.
- Carrol CL, Sala K, Zucker AR, Schramm CM. Pulmonary mechanics
following albuterol therapy I mechanically ventilated infants with
bronchiolitis. J Asthma 2012;49(7):688-296.
- Schramm CM, Sala KA, Carroll CL. Clinical examination does not predict
response to albuterol in ventilated infants with bronchiolitis.
Pediatr Crit Care Med 2017;18(1):e18-e23.
- Khan SY, O’Driscoll BR. Is nebulized saline a placebo in COPD?BMC Pulm Med . 2004;4:9.
- House SA, Gadomski AM, Ralston SL. Evaluating the placebo status of
nebulized normal saline in patients with acute viral bronchiolitis: A
systematic review and meta-analysis. JAMA Pediatr 2020;174(3):250-259.
- Van der Schans CP. Bronchial mucus transport. Resp Care
2007;52(9):1150-1158.
- Rogers DF. Mucoactive agents for airway mucus hypersecretory diseases.
Resp Care 2007;52(9):1176-1193.
- Schuepp KG, Straub D, Moller A, Wildhaber JH. Deposition of aerosols
in infants and children. Journal of Aerosol Medicine
2004;17(2):153-156.
- Amirav I, Newhouse MT. Deposition of small particles in the developing
lung. Pediatric Respiratory Reviews 2012;13:73-78.
- Fink JB. Aerosol delivery to ventilated infants and pediatric
patients. Respiratory Care 2004;49(6):653-665.
- Dubus JC, Vecellio L, de Monte M, Fink JB, Grimbert D, Montharu J,
Valat C, Behan N, Diot P. Aerosol deposition in neonatal ventilation.
Pediatric Res 2005;58(1):10-4.
- Berlinski A, Willis JR. Effect of tidal volume and nebulizer type and
position on albuterol delivery in a pediatric model of mechanical
ventilation. Respiratory Care 2015;60(10):1424-1430.
- Johnston DA, Gilmore TW, Gosselin KP. A comparison of metered-dose
inhaled albuterol vs endotracheal liquid bolus albuterol for treatment
of bronchoconstriction. Resp Care 2015; 60(5)627-635.
- ElHansy MHE, Boules ME, El Essawy AFM, Al-Kholy MB, Abdelrahman MM,
Said ASA, Hussein RRS, Abdelrahim ME. Inhaled salbutamol dose
delivered by jet nebulizer, vibrating mesh nebulizer and metered dose
inhaler with spacer during invasive mechanical ventilation. Pulm
Pharmacol Ther 2017;45:159-163.